Atrial Fibrillation and Stroke Prevention in the Community | Zendy

Janice O’Connell | Zendy; Christopher S. Gray | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atrial Fibrillation and Stroke Prevention in the Community

Author(s) -

Janice O’Connell,

Christopher S. Gray

Publication year - 1996

Publication title -

age and ageing

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.014

H-Index - 143

eISSN - 1468-2834

pISSN - 0002-0729

DOI - 10.1093/ageing/25.4.307

Subject(s) - medicine , atrial fibrillation , warfarin , stroke (engine) , aspirin , secondary prevention , primary prevention , randomized controlled trial , cardiology , risk factor , physical therapy , disease , mechanical engineering , engineering

Atrial fibrillation (AF) is an important and independent risk factor for stroke, particularly in elderly people. The efficacy of treatment with warfarin and aspirin in primary and secondary stroke prevention in AF has been demonstrated in randomized clinical trials. In a demographic study, we examined the prevalence of AF in patients registered with a general practice in the North East of England; 91 patients with known AF were identified, 69 with chronic AF and 22 with paroxysmal AF. The mean duration of the arrhythmia was 6.43 years and the prevalence of AF increased with age. There was a high prevalence of cerebrovascular disease in AF patients. The majority of AF patients were not receiving therapy with aspirin or warfarin as primary or secondary stroke prevention. If strategies for stroke prevention in AF are to be applied to the community, general practitioners will need to play a more active part.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research